Normal view MARC view ISBD view

Advances in the treatment and prevention of Lyme borreliosis. [electronic resource]

By:

Wormser, Gary P

Contributor(s):

Producer: 20051025Description: 381-4 p. digitalISSN:

0043-5325

Subject(s):

Online resources:

Available from publisher's website

In: Wiener klinische Wochenschrift vol. 117

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Comparative Study; Editorial; Review

There are no comments on this title.

to post a comment.

Back to results

141 Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
by Bitran, J D
142 Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer.
by Nabhan, C
143 Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies.
by Manji, H K
144 Survival of patients with localized histiocytic lymphoma.
by Bitran, J D
145 Multimodality therapy of stage III adenocarcinoma of the breast.
by Bitran, J D
146 A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
by Masters, G A
147 A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
by Vokes, E E
148 Breast conserving surgery and definitive irradiation for early stage breast cancer.
by Hallahan, D E
149 Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypes.
by Albain, K S
150 Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience.
by Madej, P J
151 Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
by Hoffman, P C
152 Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast.
by Shapiro, C M
153 Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
by Bitran, J D
154 Small-cell carcinoma of the lung: the prognostic significance of stage on survival.
by Cooksey, J A
155 Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.
by Fleming, G F
156 Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.
by Ratain, M J
157 Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
by Yanovich, S
158 Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma.
by Sweet, D L
159 Small-cell carcinoma of the lung: a five-year experience with combined modality therapy.
by Hoffman, P C
160 Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.
by Gale, R P